[1]
Styczkiewicz, K., Plata, P. and PolityƄska, K. 2026. Should age disqualify from life-prolonging therapy? Successful adjuvant immunotherapy in an 88-year-old octogenarian with melanoma and high cardiovascular risk . OncoReview. 15, 4(60) (Mar. 2026), 62-66. DOI:https://doi.org/10.24292/01.OR.164222226.